Probiotics may reduce risk of VAP in ICU patients

06/17/2010 | Science Blog

Daily probiotic therapy halved the risk of ventilator-associated pneumonia in a select group of patients in the intensive care unit, U.S. researchers found. The study, which used twice-daily doses of Lactobacillus rhamnosus, also showed that the treatment reduced the amount of antibiotics needed after almost five years.

View Full Article in:

Science Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC
Principal, Global Compliance Operations
DJO Global
Vista, CA
Executive Director - Well Sense Health Plan
Well Sense Health Plan
Manchester, NH